CD274 and non-small cell lung carcinoma: However, patients with NSCLC with <4.7% PD-L1 expression on tumor cells or <6.3% PD-L1 expression on TAMs exhibited better five-year OS compared to patients with high PD-L1 expression in tumor cells or macrophages in a study by Sepesi et al.